Amphastar Pharmaceuticals Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Direxion Daily Semiconductor Bear 3X Shares trades at $42.97. Which is the better fit depends on your goals.
| AMPH | SOXS | |
|---|---|---|
Market Cap | $863.95M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $30.81 | $1.49K |
52-Week Low | $16.87 | $32.50 |
Enterprise Value | $1.26B | — |
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $42.08, down 6.18% over 24 hours amid a bearish technical signal. Recent news highlights its inverse leverage benefiting from semiconductor sector weakness, with a 1:10 stock split scheduled for July 2026. Technical indicators show oversold conditions with an RSI of 8.06, while support sits at $40.
The outlook remains risky due to its leveraged inverse structure, which amplifies losses if semiconductor stocks rebound. Opportunities exist for short-term traders betting on continued chip sector declines, but long-term holders face decay and volatility risks. Key risks include AI-driven semiconductor rallies and macroeconomic shifts affecting tech demand.
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →